Date: Wednesday 8 June, 4-5pm
Venue: Online
Register: Here
Next from the series of CATS organised Gateway to Translation (G2T) webinars, Dr Ramtin Agah, co-Founder and Chief Medical Officer of RenovoRx, Inc., will discuss recent innovations in solid tumor therapy and the implications of targeted therapy options - in particular the opportunities and challenges associated with his company's proprietary trans-arterial microperfusion technology. This webinar will be chaired by Prof Kourosh Saeb-Parsy, Professor of Transplantation & Honorary Consultant, University of Cambridge. Please, register here.